Non-alcoholic fatty liver disease (NAFLD)

The prevalence of non-alcoholic fatty liver disease (NAFLD) is estimated to be between 20% and 30% in the general population. This prevalence is significantly higher in individuals with type 2 diabetes, reaching approximately 70-80%. The risk of developing advanced liver fibrosis and cirrhosis is higher for diabetic patients. Due to the increasing rates of obesity, […]